Study brain aging? Using a tamoxifen inducible cre model and want to TAM treat at an old age? Should work great. Check out our validation study: https://t.co/fuLwIpGZzD
Our new work examining cell type-specific DNA modification patterns in the brain demonstrates the importance of differentiating between mC and hmC in neuroepigenomic analyses. https://t.co/BhYFzjmh1q
Excited that our work on microglial MHC-I with aging and Alzheimer's is now published. Congratulations to Collyn Kellogg on his first paper as a 1st author! https://t.co/Jbvi39O38C
NIA/NIH F99-K00 award for Victor Ansere from the FreemanLab @OMRF. This will support Victor's graduate work in plasma transfer treatments for aging and subsequent post-doc. Innovative award transition training award from @NIHAging. Congratulations to Victor!
Big day & massive congratulations to @OcanasSR from our group. She is an NIH Early Independence Awardee @NIH_CommonFund#NIHHighRisk. 1st award of this type in Oklahoma. We look forward to Sarah and her group being part of Genes & Human Disease Program at @OMRF.
Dr. Freeman has been received a Biomedical Laboratory Research and Development VA Research Career Scientist Award. @VAResearch is a critical funder of biomedical research to improve the lives of our nation's Veterans and all Americans.
In this #eNeuro study, @OcanasSR et al.@FreemanLabOMRF analyzed tissue dissociation & microglial sorting techniques in terms of yield, purity, & activational confounds to provide recommendations for optimal microglial isolation based on experimental needs.
https://t.co/lZNku2gevw
Congratulations to PhD student Sarah Ocanas in the lab on her new publication - https://t.co/TwpUvdtNU7. A deep investigation of isolating microglia without causing artifacts.
OMRF scientists Dr. Bill Freeman and Dr. Benjamin Miller recently received Impetus Grants to pursue bold ideas in #AgingBiology. https://t.co/deZtMhq1GM